FTXH
First Trust Nasdaq Pharmaceuticals ETF
Price Chart
Latest Quote
$36.23
+0.43 (+1.19%)
Current Price
| Previous Close | $35.80 |
| Open | $35.91 |
| Day High | $36.37 |
| Day Low | $35.91 |
| Volume | 6,224 |
Fund Information
| Quarterly Dividend / Yield | N/A / 1.20% |
| Net Assets | $35.04M |
| Expense Ratio | 0.60% |
| Category | Health |
| Fund Family | First Trust |
| Net Asset Value | $35.82 |
| Premium/Discount | 1.13% |
| Quarterly Dividend Yield | 1.20% |
| P/E Ratio | 25.13 |
| Exchange | NGM |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $35.31 |
| SMA50 | $34.60 |
| SMA200 | $32.68 |
| RSI | 72.85 |
| ATR | 0.5572 |
| Rel Volume | 0.66 |
Performance History
| Week | +1.15% |
| Month | +4.90% |
| Quarter | +9.64% |
| 6 Months | +11.76% |
| YTD | +9.54% |
| Year | +44.11% |
| 3 Years | +42.77% |
| 5 Years | +48.89% |
| 10 Years | +100.35% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $36.22 | 6,224 |
| 2026-06-22 | $35.83 | 9,400 |
| 2026-06-18 | $35.38 | 4,800 |
| 2026-06-17 | $35.64 | 5,100 |
| 2026-06-16 | $35.67 | 10,000 |
| 2026-06-15 | $35.81 | 10,700 |
| 2026-06-12 | $36.01 | 3,300 |
| 2026-06-11 | $36.09 | 19,600 |
| 2026-06-10 | $35.33 | 16,900 |
| 2026-06-09 | $35.64 | 42,400 |
| 2026-06-08 | $35.12 | 5,400 |
| 2026-06-05 | $35.44 | 11,600 |
| 2026-06-04 | $35.39 | 8,900 |
| 2026-06-03 | $34.53 | 12,000 |
| 2026-06-02 | $33.95 | 2,700 |
| 2026-06-01 | $34.40 | 1,800 |
| 2026-05-29 | $35.02 | 2,200 |
| 2026-05-28 | $35.17 | 9,900 |
| 2026-05-27 | $34.86 | 3,000 |
| 2026-05-26 | $34.67 | 3,200 |
About First Trust Nasdaq Pharmaceuticals ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
đ° Latest News
Pharma ETFs in Spotlight Following Robust Q3 Earnings Results
Zacks âĸ 2025-11-14T12:59:00Z
Shine a Light on Healthcare ETFs Amid National Alzheimer's Awareness Month
Zacks âĸ 2025-11-13T13:07:00Z
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook
Zacks âĸ 2025-10-16T12:52:00Z
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Zacks âĸ 2025-09-26T13:24:00Z
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook
Zacks âĸ 2025-07-17T15:00:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.